Search
for

    Sort by

    Research 631–660 of 1000+

    1. No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours Clinical Endocrinology · 2012 · 17 citations
    2. The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals Brazilian Journal of Medical and Biological Research · 2003 · 17 citations
    3. 5α-Reductase Inhibitors, Chemical and Clinical Models Steroids · 1998 · 17 citations
    4. FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 17 citations
    5. Androgenic disorders of women: Diagnostic and therapeutic decision making The American Journal of Medicine · 1995 · 17 citations
    6. Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters BMC Genomics · 2018 · 16 citations
    7. Do Different Diagnostic Criteria Impact Polycystic Ovary Syndrome Diagnosis for Adolescents? Journal of Pediatric and Adolescent Gynecology · 2017 · 16 citations
    8. The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia Skin Pharmacology and Physiology · 2015 · 15 citations
    9. Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome? Dermatology Research and Practice · 2015 · 15 citations
    10. Alopecia and Hirsuties Drugs · 1988 · 15 citations
    11. Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome Scientific Reports · 2023 · 14 citations
    12. Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome Iraqi Journal of Science · 2019 · 14 citations
    13. Oral medications for central serous chorioretinopathy: a literature review Eye · 2019 · 14 citations
    14. Gynecologic and andrologic dermatology and the metabolic syndrome Clinics in Dermatology · 2017 · 14 citations
    15. Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk Fertility and Sterility · 2016 · 14 citations
    16. Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia Current Medicinal Chemistry · 2006 · 14 citations
    17. Antiandrogen therapy for androgenetic alopecia Expert Review of Dermatology · 2006 · 14 citations
    18. Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1 The Journal of Clinical Endocrinology and Metabolism · 1998 · 14 citations
    19. Female Androgenic Alopecia Archives of Dermatology · 1986 · 14 citations
    20. Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment Scientific Reports · 2024 · 13 citations
    21. Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome Physiological Research · 2019 · 13 citations
    22. Finasteride and androgenic alopecia; from therapeutic options to medical implications Journal of Dermatological Treatment · 2019 · 13 citations
    23. Morpho‐regulation in diverse chicken feather formation: Integrating branching modules and sex hormone‐dependent morpho‐regulatory modules Development, Growth & Differentiation · 2018 · 13 citations
    24. Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates The Journal of Steroid Biochemistry and Molecular Biology · 1995 · 13 citations
    25. Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach Acta Neurologica Belgica · 2019 · 12 citations
    26. Analysis of changes in microRNA expression profiles in response to the troxerutin-mediated antioxidant effect in human dermal papilla cells Molecular Medicine Reports · 2015 · 12 citations
    27. Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link? PubMed · 2010 · 12 citations
    28. Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis British Journal of Dermatology · 1997 · 12 citations
    29. 25 years of ERβ: a personal journey Journal of molecular endocrinology · 2021 · 11 citations
    30. Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs Cancers · 2019 · 11 citations